Document Detail

The role of the right ventricle in pulmonary arterial hypertension.
MedLine Citation:
PMID:  22130817     Owner:  NLM     Status:  In-Data-Review    
Although changes in the pulmonary vasculature are the primary cause of pulmonary arterial hypertension (PAH), severity of symptoms and survival are strongly associated with right ventricular function, and right heart failure is the main cause of death in patients with PAH. Echocardiography and cardiac magnetic resonance imaging allow noninvasive evaluation of right ventricular function and structure, and a number of indices have been shown to have potential prognostic value in PAH. Given the importance of the right ventricle in PAH, preservation and improvement of its function should be important aspects of therapy; however, there are currently few data specifically related to this aspect of treatment response. Simple, reproducible, noninvasive measures of right ventricular function would help to improve the management of patients with PAH, and to provide tools with which to help establish the optimal therapeutic approach to manage not only the effects of the disease on the pulmonary vasculature, but also to support and improve right ventricular function.
A Vonk Noordegraaf; N Galiè
Related Documents :
10567277 - Patient outcome and valve performance following a second aortic valve homograft replace...
21757577 - Intermittent hypoxia augments pulmonary vascular smooth muscle reactivity to no: regula...
21940767 - Mast cell inhibition improves pulmonary vascular remodeling in pulmonary hypertension.
6186827 - Probable herpes simplex pneumonia after aortic valve replacement.
23551337 - Radiographic characterization of presumed plate-like atelectasis in 75 nonanesthetized ...
6839817 - The acquired nonprecordial peripheral pulmonary murmur of pulmonary embolism.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  European respiratory review : an official journal of the European Respiratory Society     Volume:  20     ISSN:  1600-0617     ISO Abbreviation:  Eur Respir Rev     Publication Date:  2011 Dec 
Date Detail:
Created Date:  2011-12-01     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9111391     Medline TA:  Eur Respir Rev     Country:  Denmark    
Other Details:
Languages:  eng     Pagination:  243-53     Citation Subset:  IM    
VU University Medical Center, Amsterdam, The Netherlands. # University of Bologna, Bologna, Italy.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Prognostic factors in pulmonary arterial hypertension: assessing the course of the disease.
Next Document:  Optimal management of severe pulmonary arterial hypertension.